版本:
中国

BRIEF-Dicerna reports Q4 loss per share $0.68

March 30 Dicerna Pharmaceuticals Inc

* Dicerna reports fourth quarter and full year 2016 financial and operational results

* Dicerna Pharmaceuticals Inc says anticipates that it will have sufficient cash to fund execution of company's current operating plan into 2019

* Qtrly loss per share $0.68 Source text for Eikon: Further company coverage:

我们的标准: 汤森路透“信任原则

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐